Patents by Inventor Claus Crone Fuglsang

Claus Crone Fuglsang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial activity of laccases
    Publication number: 20010025018
    Abstract: A method for antimicrobial treatment of microorganisms and/or viruses which involves treating the microorganisms and/or viruses with an effective amount of a fungal laccase and one or more enhancers in the presence of oxygen, the enhancers having the formula: 1
    Type: Application
    Filed: December 22, 2000
    Publication date: September 27, 2001
    Inventors: Charlotte Johansen, Anders Hjelholt Pedersen, Claus Crone Fuglsang
  • Cellulose binding domains (CBDs) for oral care products
    Patent number: 6264925
    Abstract: The present invention relates to an oral care composition comprising a Cellulose Binding Domain and further ingredient conventionally used in oral care compositions, oral care products, and the use of CBDs for oral care purposes.
    Type: Grant
    Filed: April 8, 1999
    Date of Patent: July 24, 2001
    Assignee: Novozymes A/S
    Inventors: Claus Crone Fuglsang, Rie Tsuchiya
  • Starch binding domains (SBDs) for oral care products
    Patent number: 6207149
    Abstract: The present invention relates to an oral care composition comprising a Starch Binding Domain and further ingredients conventionally used in oral care compositions, oral care products, and the use of SBDs for oral care purposes.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: March 27, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Claus Crone Fuglsang, Rie Tsuchiya
  • Carbohydrate oxidase and use thereof in baking
    Patent number: 6165761
    Abstract: The properties of dough or bread can be improved by the addition of a carbohydrate oxidase which can oxidize the reducing end of an oligosaccharide more efficiently than the corresponding monosaccharide, e.g., preferentially oxidizing maltodextrins or cellodextrins over glucose. A novel carbohydrate oxidase having the capability to oxidize maltodextrins and cellodextrins more efficiently than glucose may be obtained from a strain of Microdochium, particularly M. nivale. The amino acid sequence of the novel carbohydrate oxidase has very low homology (<20% identity) with known amino acid sequences.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: December 26, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Palle Schneider, S.o slashed.ren Christensen, Lone Dybdal, Claus Crone Fuglsang, Feng Xu, Elizabeth Golightly
  • Recombinant enzyme with dextranase activity
    Patent number: 6156553
    Abstract: The present invention relates to a cloned DNA sequence encoding an enzyme with dextranase activity, a recombinant expression vector comprising said DNA sequence, a filamentous fungus host cell, a method for producing said recombinant dextranase, and the isolated and purified enzyme.The invention also relates to compositions comprising the recombinant enzyme, oral care compositions and products and the use for removing of dental plaque.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: December 5, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Tove Christensen, Claus Crone Fuglsang, Torben Halkier, Charlotte Johansen
  • Method for reducing phosphorus content of edible oils
    Patent number: 6143545
    Abstract: The present invention relates to a method for reducing the content of phosphorous containing components in an edible oil comprising a high amount of non-hydratable phosphorus content, wherein said method comprises use of a phospholipase. Further the present invention relates to an enzyme with phospholipase activity, a cloned DNA sequence encoding the enzyme with phospholipase activity, a method of producing the enzyme, and the use of said enzyme for a number of industrial applications.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: November 7, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Ib Groth Clausen, Shamkant Anant Patkar, Kim Borch, Martin Barfoed, Kim Clausen, Claus Crone Fuglsang, Lone Dybdal, Torben Halkier
  • Method for reducing phosphorus content of edible oils
    Patent number: 6103505
    Abstract: The present invention relates to a method for reducing the content of phosphorous containing components in an edible oil comprising a high amount of non-hydratable phosphorous content, wherein the method comprises use of a phospholipase. Further the present invention relates to an enzyme with phospholipase activity, a cloned DNA sequence encoding the enzyme with phospholipase activity, a method of producing the enzyme, and the use of enzyme for a number of industrial applications.
    Type: Grant
    Filed: December 9, 1997
    Date of Patent: August 15, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Ib Groth Clausen, Shamkant Anant Patkar, Kim Borch, Martin Barfoed, Kim Clausen, Claus Crone Fuglsang, Lone Dybdal, Torben Halkier
  • Peniophora phytase
    Patent number: 6060298
    Abstract: The present invention relates to an isolated polypeptide exhibiting phytase activity, the corresponding cloned DNA sequences, a process for preparing the polypeptide, and the use thereof for a number of industrial applications, in particular in animal feed. The novel phytase is derived from Peniophora lycii and has some interesting features, such as high initial affinity for the 6-position of phytic acid, a high intial rate of liberating phosphate from phytic acid and an exceptionally high specific activity.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: May 9, 2000
    Assignee: Novo Nordisk A/S
    Inventors: S.o slashed.ren Flensted Lassen, Lisbeth Bech, Claus Crone Fuglsang, Anders Ohmann, Jens Breinholt, Peter Rahbet stergaard
  • Peniophora phytase
    Patent number: 6054306
    Abstract: The present invention relates to an isolated polypeptide exhibiting phytase activity, the corresponding cloned DNA sequences, a process for preparing the polypeptide, and the use thereof for a number of industrial applications, in particular in animal feed. The novel phytase is derived from Peniophora lycii and has some interesting features, such as high initial affinity for the 6-position of phytic acid, a high intial rate of liberating phosphate from phytic acid and an exceptionally high specific activity.
    Type: Grant
    Filed: December 23, 1998
    Date of Patent: April 25, 2000
    Assignee: Novo Nordisk A/S
    Inventors: S.o slashed.ren Flensted Lassen, Lisbeth Bech, Claus Crone Fuglsang, Anders Ohmann, Jens Breinholt, Peter Rahbet stergaard
  • Phytase polypeptides
    Patent number: 6039942
    Abstract: The present invention relates to isolated polypeptides having phytase activity, the corresponding cloned DNA sequences, a process for preparing such polypeptides, and the use thereof for a number of industrial applications. In particular, the invention relates to phytases derived from the phyllum Basidiomycota, phytases of certain consensus sequences and fungal 6-phytases.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: March 21, 2000
    Assignee: Novo Nordick A/S
    Inventors: Soren Flensted Lassen, Lisbeth Bech, Anders Ohmann, Jens Breinholt, Claus Crone Fuglsang, Peter Rahbek Ostergaard
  • Polypeptides having mutanase activity and nucleic acids encoding same
    Patent number: 5874275
    Abstract: The present invention relates to polypeptides having mutanase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to oral cavity compositions and methods for degrading mutan.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: February 23, 1999
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Randy M Berka, Stephan Christgau, Torben Halkier, Jeff Shuster, Claus Crone Fuglsang
  • Penicillium purpurogenum mutanases and nucleic acids encoding same
    Patent number: 5853702
    Abstract: The present invention relates to polypeptides having mutanase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to oral cavity compositions and methods for degrading mutan.
    Type: Grant
    Filed: February 7, 1997
    Date of Patent: December 29, 1998
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Randy M. Berka, Stephan Christgau, Torben Halkier, Jeff Shuster, Claus Crone Fuglsang